INDEPENDENT NEWS

F&P Healthcare files patent complaint against rival ResMed

Published: Tue 11 Sep 2018 01:14 PM
Fisher & Paykel Healthcare has filed a complaint against its rival ResMed, alleging some of ResMed's masks used to treat obstructive sleep apnea infringe its patents.
Auckland-based F Healthcare said it has filed a complaint with the US International Trade Commission, alleging the AirFit P10 for Her masks and AirFit P10 for AirMini masks infringe five of its patents and seeking a permanent exclusion order and cease and desist order to prevent the sale and importation of the AirFit P10 range of masks in the US.
“Over the past 20 years, Fisher & Paykel Healthcare has built a significant portfolio of more than 2,000 issued and pending patents," F Healthcare managing director Lewis Gradon said in a statement. "We have developed unique mask technology that has provided improved care and outcomes for patients with OSA and we take infringement of our intellectual property rights very seriously.”
F Healthcare's action comes hot on the heels of a complaint to the commission from ResMed earlier this month, where the US company sought to ban the importation and sale of F Healthcare's Simplus full face mask, Eson nasal mask and Eson 2 nasal mask in the US, and separately lodged a new suit in the US district court accusing the Kiwi firm of patent infringement and seeking damages plus an injunction against future sales of the masks.
The rival companies have been locked in litigation since 2016 spanning the US, UK, Europe, New Zealand and Australia.
F Healthcare spent $15.6 million on litigation in the year ended March 31, 2018, down from $20.7 million a year earlier. F Healthcare said today its earnings guidance for the 2019 financial year remains unchanged as its latest update on Sept. 3 allowed for legal costs of the latest action. That guidance said the patent dispute would cut annual earnings by as much as $10 million to a range of $205 million to $210 million in the year ending March 31, 2019, from a previous forecast of $215 million.
F Healthcare shares slipped 0.3 percent to $14.75, having gained 15 percent over the past year.
BusinessDesk
Independent, Trustworthy New Zealand Business News
The Wellington-based BusinessDesk team provides a daily news feed for a serious business audience.
Contact BusinessDesk
Email:

Next in Business, Science, and Tech

Broad-based growth as GDP rises 1 percent in June quarter
By: Statistics New Zealand
Judgment: NZ Steel v Minister of Consumer Affairs
By: New Zealand High Court
NZ banks accelerate lending in June quarter
By: BusinessDesk
Annual current account deficit widens to $9.5 billion
By: Statistics New Zealand
UPDATE: Stronger than expected growth
By: BusinessDesk
Economic growth figures highlight Govt fallacy
By: New Zealand National Party
Latest economic figures expose gloom merchants
By: New Zealand Council of Trade Unions
Whooshkaa! Our growth is better than you think
By: Kiwibank
Banks Slam Govt's Reserve Bank Bill
By: ACT New Zealand
No Need for Knee-Jerk Bank Bashing in New Zealand
By: ACT New Zealand
Near-record exports see current account deficit shrink
By: Statistics New Zealand
NZ dollar falls vs Aussie
By: BusinessDesk
Dairy product prices fall
By: BusinessDesk
View as: DESKTOP | MOBILEWe're in BETA! Send Feedback © Scoop Media